Ealixir, Inc.
EAXR · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4 | $5 | $4 | $4 |
| % Growth | -28.2% | 22% | 17% | – |
| Cost of Goods Sold | $0 | $1 | $1 | $1 |
| Gross Profit | $3 | $4 | $3 | $3 |
| % Margin | 86.3% | 74.1% | 78.8% | 75.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $5 | $3 | $3 |
| SG&A Expenses | $4 | $5 | $3 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4 | $5 | $3 | $4 |
| Operating Income | -$0 | -$1 | $0 | -$1 |
| % Margin | -11.2% | -19.3% | 6.5% | -24.9% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | $1 |
| Pre-Tax Income | $0 | -$1 | $0 | -$0 |
| Tax Expense | $0 | -$1 | $0 | $0 |
| Net Income | $0 | -$1 | $0 | -$0 |
| % Margin | 2.6% | -23.5% | 3.4% | -9.5% |
| EPS | 0.002 | -0.015 | 0.003 | -0.007 |
| % Growth | 111% | -600% | 139.7% | – |
| EPS Diluted | 0.002 | -0.015 | 0.003 | -0.007 |
| Weighted Avg Shares Out | 60 | 59 | 48 | 46 |
| Weighted Avg Shares Out Dil | 60 | 59 | 48 | 46 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$1 | $0 | -$0 |
| % Margin | 6.5% | -26.5% | 6.3% | -6.9% |